AboutContact usRSS
dotsbydots
SEARCHCONTACT US

Buzz

Most popular

Daily
Weekly
1
Lusix lost $65 million as lab-grown diamond prices plummeted
2
Intel ends car leasing program in latest cost-cut
3
Israel urged to dump ‘Hasbara’, instead pivoting to highlight its place in the world
4
Intel shutting down startup accelerator Ignite amid massive cuts
5
The Gili Ra’anan model: Questions emerging from Cyberstarts' remarkable success
More news

Pfizer

20 stories about Pfizer
דוד הראל מייסד מנכ"ל CytoReason

CytoReason raises $80 million, including from NVIDIA and Pfizer, to scale its AI disease models

17.07.24|Meir Orbach
The Israeli startup provides therapeutic area leaders with molecular-level insights and valuable AI tools to make data-driven decisions, helping them improve the probability of phase 2 success and optimize their R&D portfolio. 
Pfizer Chairman and CEO Albert Bourla with the Technion delegation led by Technion President Professor Uri Sivan

Technion and Pfizer sign agreement to boost drug development with AI

15.01.23|CTech
The Technion aims to advance technological and medical developments by identifying new technologies and various digital tools with potential industrial application
מייסדי סייטוריזן, מימין: דוד הראל, פרופ' שי שן-אור, אלינה סטרוסבצקי, רנו גוז'ו

CytoReason raises $20 million from Pfizer for AI drug discovery and development platform

20.09.22|Meir Orbach
Pfizer will also have options to license the Israeli startup’s platform and disease models, and fund supplementary project support, in a deal potentially worth up to $110 million over the next five years
מנת חיסון פייזר קורונה covid 19

Israeli study reveals South African variant may evade Pfizer vaccine

12.04.21|Reuters
Almost 53% of Israel's 9.3 million population has received both Pfizer doses, and has largely reopened its economy in recent weeks
ד"ר טל זקס חיסון מודרנה קורונה

Moderna CMO suggests Israel is on its radar for new vaccine production facility

25.02.21|Sophie Shulman
Tal Zaks says the drugmaker has already produced a booster shot to counter the South African variant, says his mom in Israel received the competition’s vaccine
חיסון קורונה מתחסן צעיר

Proof in the numbers: Israeli HMO reinforces Covid-19 vaccine efficacy findings by Pfizer

18.02.21|Reuters
Only 608 people out of a total 602,000 had tested positive for Covid-19 more than a week after receiving second dose
פייזר חיסונים קורונה

Survey finds majority of Israelis aren’t worried about sharing vaccine data with drug companies

04.02.21|CTech
While Israelis overwhelmingly disagree with sharing their medical data with state security agencies, they are willing to do so with drugmakers in exchange for Covid-19 vaccines
זריקה חיסון קורונה אחות בית חולים איכילוב

Israel includes teens in vaccination drive, eyeing exams

24.01.21|Reuters
As part of the nationwide vaccination campaign, teens will receive the new Covid-19 vaccines as well so that they may return to school
תור חיסון קורונה כיכר רבין תל אביב

Dissecting the data-sharing deal: Should Israelis be worried about Pfizer getting private info?

19.01.21|Dov Greenbaum
Israel truly has an opportunity to be a light unto the nations by helping everyone else optimally distribute their vaccines in their own jurisdictions, but at what cost?
תור חיסון קורונה כיכר רבין תל אביב

Human experimentation oversight committee wants to approve Israel-Pfizer data-sharing deal

19.01.21|Adrian Filut
Does research to examine Covid-19 vaccine’s effectiveness at achieving herd immunity risk citizens’ privacy?
תור למתן חיסון נגד קורונה 1

How did an Israeli robotics company catch Elon Musk's attention and why is every criminal on the planet your next-door neighbor?

18.01.21|CTech
CTech Daily Roundup: Meet the Israeli company that has ballooned to a valuation of $1.4 billion despite nano-sized sales
בנימין נתניהו יולי אדלשטיין הגעה של מטוס DHL נתב"ג ישראל משלוח חיסון חיסונים נגד קורונה פייזר

Responding to calls for transparency, Israel publishes contract of data-sharing vaccine deal with Pfizer

17.01.21|CTech
Redacted document appears to confirm health ministry statements that only publicly available information will be shared
מוסף שבועי 14.1.21 רון דיסקין

“We’re lucky that the mutations only affected the rate of infection, they could have created a far more violent virus”

16.01.21|Diana Bahur-Nir
Prof. Ron Diskin, an expert on deadly viruses, isn’t worried that the new Covid-19 vaccine will lose its effectiveness but is concerned about millennials’ cavalier attitude toward the disease
אורלי טורי טרייוונצ'רס Orli Tori Triventures

Israel’s one of a kind healthcare system is a rare opportunity for Pfizer

12.01.21|Elihay Vidal
The 25 years of accumulating digital medical data can help Israel optimize its Covid-19 vaccination campaign and benefit all of humankind, says Orli Tori, a partner at Triventures ARC
Nimrod Kozlovski

Israel can use medical data to defeat the virus without violating people’s privacy

11.01.21|James Spiro
In exchanging digitized healthcare data for vaccination shots, Prime Minister Benjamin Netanyahu assured citizens their personal data is safe. Dr. Nimrod Kozlovski, Head of Tech and Regulation at HFN, shares his thoughts on the deal
תור חיסון קורונה כיכר רבין תל אביב

How is technology and data helping Israel become the first country to vanquish Covid-19?

10.01.21|Elihay Vidal
Israel is well on its way to vaccinating its entire adult population and in exchange for delivering millions of vaccine doses, the government has pledged to give drugmaker Pfizer medical data on the millions of vaccine recipients from the health system’s vast databases
תור למתן חיסון נגד קורונה 1

These are the key ingredients of Israel's rapid Covid-19 vaccine rollout recipe

06.01.21|Reuters
Two weeks into its vaccination drive, Israel has reached nearly 15% of the population by paying premium prices, relying on universal healthcare, and minimizing waste
אהרון אהרון מנכ'ל רשות החדשנות 30.9.20

Pfizer, AstraZeneca, Merck, and Teva win tender for new Israeli Innovation Lab

27.12.20|James Spiro
The lab, which is set to research digital health and computational biology, has a government budget of $9.9 million
תחנת חיסון קורונה קופת חולים מכבי

Will the quickly developed vaccines deliver Covid-19 a knockout blow?

13.12.20|Sophie Shulman
An urgent global crisis, near-limitless funds, and a scientific development ripe for use combined to produce rapid results, but will today’s vaccines eradicate the pandemic?
מנות חיסון חיסונים פייזר קורונה

Survey: One-third of Israelis would prefer to take homegrown Covid-19 vaccine

10.12.20|James Spiro
The results come a day after America’s Pfizer/BioNTech vaccine touches down for distribution
More Articles